Benzinga | Mar 17, 2021 08:07AM EDT

Wells Fargo Maintains Equal-Weight on Amphastar Pharmaceuticals, Lowers Price Target to $20

Wells Fargo maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Equal-Weight and lowers the price target from $21 to $20.